[ad_1]
The EMA has rated the coronavirus vaccine developed jointly by British-Swedish pharmaceutical company AstraZeneca and the University of Oxford as safe, but believes that more evidence is needed, the European Union pharmacovigilance agency said.
Across Europe, several countries have stopped being immunized with this vaccine after some patients developed blood disorders after receiving the vaccine.
Latvia and Lithuania have been vaccinated with AstraZeneca again on Friday, the health ministers of the two countries said. Lithuanian Health Minister Arunas Dulkys said confidence in AstraZeneca would be vaccinated on Friday by President Gitanas Nauseda, Prime Minister Ingrida Simonyte, the Speaker of Parliament and himself.
Vaccination with AstraZeneca will resume in Bulgaria on Friday, the head of the drug surface authority said on Thursday. Bogdan Kirilov claimed that a study of a woman who died hours after vaccination with AstraZeneca found no direct link between vaccination and death.
Camilla Stoltenberg, director of the Norwegian Institute of Public Health, said the suspension of the vaccine, ordered on March 11, would remain in effect. The institute will take a position on the issue at the end of next week.
Before the EMA announcement, Norwegian researchers reported finding signs of a strong immune response in patients vaccinated with AstraZeneca and showing blood clots. Pal Andre Holme, chief physician at Oslo University Hospital, said complications occurred between the third and tenth day after vaccination.
[ad_2]
